The drug coming from the 503B grey vendor is a disaster waiting to happen, clinical Liability Nightmare for some wellness influencer to write a blog about
(1) Korkushko OV, Lapin BA, Goncharova ND, Khavinson VKh, Shatilo VB, Vengerin AA, Antoniuk-Shcheglova IA, Magdich LV
10.1046/j.1432-1327.2000.01234.x 101 RogiT.TsujimotoM.NakazatoH.MizutaniS.TomodaY
Sermorelin: A more established growth hormone releaser with an FDA history and an extensive clinical track record
If a patient reduces pain but does not rebuild capacity, the tissue may still be vulnerable
But what makes this method of supplementation worth considering